|
⚲
|
| Keyboard |
| Robert Karr | |
|---|---|
| Firm | |
| Address | c/o Tioma Therapeutics, Inc 4320 Forest Park Ave, Suite 304 Saint Louis, MO 63108 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Antegrin Therapeutics Inc | 021-248662 | Executive Officer | 0.1 M of 0.6 M |
||
| Antegrin Therapeutics Inc | 021-248659 | Executive Officer | 0.6 M of 0.6 M |
||
| Tioma Therapeutics Inc | 021-245292 | Executive Officer | 33.2 M of 86.3 M |
||
| Vasculox Inc | 021-233994 | Executive Officer | 1.3 M of 2.8 M |
||
| Euclises Pharmaceuticals Inc | 021-209852 | Executive Officer | 1.9 M of 1.9 M |
||
| Tansna Therapeutics Inc | 021-203528 | Executive Officer | of 0.8 M |
||
| Joho Asia Growth Fund Ltd | 021-182430 | Director | 30.0 M | ||
| Euclises Pharmaceuticals Inc | 021-178452 | Executive Officer | 0.2 M of 0.4 M |
||
| Terpenoid Therapeutics Inc | 021-137807 | Executive Officer | 0.9 M of 1.1 M |
||
| Joho Fund Ltd | 021-136543 | Director | 756.8 M | ||
| Kempharm Inc | 021-118024 | Executive Officer | 3.5 M of 3.9 M |
||
| Joho Capital LLC | |||||
| Joho Asia Growth Partners LP | 021-136413 | Executive Officer | 149.2 M | 137.4 M | |
| Joho Partners LP | 021-136414 | Executive Officer | 3,378.4 M | 3,318.5 M | |